Paris - Delayed Quote ? EUR Sensorion SA (ALSEN.PA) Follow Compare 0.7000 -0.0040 (-0.57%) At close: November 1 at 3:23 PM GMT+1 All News Press Releases SEC Filings All SEC Filings Corporate Changes & Voting Matters Periodic Financial Reports Proxy Statements Tender Offer/Acquisition Reports Offering Registrations Why Qorvo Stock Tanked This Week The chip supplier really had a fiscal second quarter to forget. Motley Fool ? 6 hours ago QRVO These are the S&P 500’s biggest laggards for October, down by as much as 29% Super Micro joined the list after a 33% drop on Wednesday. MarketWatch ? yesterday QRVO SMCI ^GSPC S&P 500 Gains and Losses Today: Supermicro Stock Dives as Accounting Firm Resigns The S&P 500 slipped 0.3% on Wednesday, Oct. 30, as the latest GDP data showed an unexpected deceleration in economic growth during the third quarter. Investopedia ? 2 days ago SMCI ^GSPC QRVO Qorvo Shares Plunge 27%: Is This the Beginning of the End for Their Smartphone Empire? Analysts React as Qorvo Faces Major Challenges in the Smartphone Market GuruFocus.com ? 2 days ago QRVO Qorvo Stock Plummets After Chipmaker Posts Surprise Loss, Warns of Slump Qorvo reported an unexpected loss and warned of continued slowdown for the rest of the fiscal year. Investopedia ? 2 days ago QRVO Why Qorvo (QRVO) Stock Is Falling Today Shares of communications chips maker Qorvo (NASDAQ: QRVO) fell 27.7% in the afternoon session after the company reported weak third-quarter earnings, with its revenue and EPS guidance for next quarter missing analysts' expectations. The company provided weak full-year revenue and gross margin guidance due to an unfavorable shift in smartphone demand as more consumers opt for lower-priced 5G smartphones rather than mid-range options. Notably, cheaper smartphones tend to fetch lower profit margins StockStory ? 2 days ago QRVO Do Fund Managers Love Or Hate Qorvo, Inc. (QRVO)? We recently compiled a list of the BofA’s List Of AI & Semiconductor Stocks That Fund Managers Love & Hate: 16 Stocks On The Manager Radar. In this article, we are going to take a look at where Qorvo, Inc. (NASDAQ:QRVO) stands against the other AI and semiconductor stocks in BofA’s list that fund managers love […] Insider Monkey ? 2 days ago QRVO Why Qorvo Stock Just Crashed 25% Qorvo stock got a lot cheaper today, but isn't yet "cheap." Motley Fool ? 2 days ago QRVO Qorvo Stock Tumbles 26% After Earnings Beat. Here’s Why. The radio-frequency chip maker beats quarterly earnings and sales estimates but issues disappointing guidance. Barrons.com ? 2 days ago QRVO Qorvo's Q2 Earnings Surpass Estimates Despite Lower Revenues QRVO reports healthy second-quarter fiscal 2025 results despite a year-over-year decline in sales in several business verticals. Zacks ? 2 days ago QRVO Q2 2025 Qorvo Inc Earnings Call Q2 2025 Qorvo Inc Earnings Call Thomson Reuters StreetEvents ? 2 days ago QRVO Qorvo Inc (QRVO) Q2 2025 Earnings Call Highlights: Strong Revenue Growth Amidst Market Challenges Qorvo Inc (QRVO) reports an 18% sequential revenue increase, while navigating competitive pressures and strategic shifts in the smartphone market. GuruFocus.com ? 2 days ago QRVO Qorvo forecasts third-quarter results below estimates; shares down The demand for budget-friendly Android 5G smartphones is on the rise from mid-tier mobile models. Qorvo also faces tough competition from smartphone-focused chipmakers such as Qualcomm and Broadcom that are benefiting from a recovery in the Chinese smartphone market. Qorvo forecast third-quarter revenue of $900 million, plus or minus $25 million, that was below analysts' estimates of $1.06 billion, according to data compiled by LSEG data. Reuters ? 3 days ago QRVO Qorvo (QRVO) Beats Q2 Earnings and Revenue Estimates Qorvo (QRVO) delivered earnings and revenue surprises of 1.62% and 1.84%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock? Zacks ? 3 days ago QRVO Qorvo: Fiscal Q2 Earnings Snapshot GREENSBORO, N.C. (AP) — Qorvo Inc. QRVO) on Tuesday reported a loss of $17.4 million in its fiscal second quarter. The Greensboro, North Carolina-based company said it had a loss of 18 cents per share. Associated Press Finance ? 3 days ago QRVO Qorvo (NASDAQ:QRVO) Q3: Beats On Revenue But Stock Drops 11.8% Communications chips maker Qorvo (NASDAQ: QRVO) reported Q3 CY2024 results beating Wall Street’s revenue expectations, but sales fell 5.2% year on year to $1.05 billion. On the other hand, next quarter’s revenue guidance of $900 million was less impressive, coming in 14.6% below analysts’ estimates. Its non-GAAP profit of $1.88 per share was also 1.7% above analysts’ consensus estimates. StockStory ? 3 days ago QRVO Qorvo (QRVO) To Report Earnings Tomorrow: Here Is What To Expect Communications chips maker Qorvo (NASDAQ: QRVO) will be announcing earnings results tomorrow after the bell. Here’s what you need to know. StockStory ? 4 days ago QRVO Qorvo Set to Report Q2 Results: Will Revenue Decline Impact Earnings? QRVO is expected to witness a top-line decline year over year in the second quarter of fiscal 2025, owing to weakness in some end markets and stiff competition. Zacks ? 9 days ago QRVO Analysts Say Apple AI Would Not Be a Catalyst for Qorvo Inc (NASDAQ:QRVO) We recently published a list of Top 10 Trending AI Stocks to Watch. Since Qorvo Inc (NASDAQ:QRVO) ranks 10th on the list, it deserves a deeper look. Wall Street continues to gain momentum amid the latest earnings season and analysts are wondering whether we are still up for soft landing. Mohamed El-Erian, Allianz chief economic advisor, talked about […] Insider Monkey ? 13 days ago QRVO Sensorion Announces its Participation in the 31st Annual Congress of the European Society of Gene and Cell Therapy and the Presentation of Several Posters on GJB2-GT MONTPELLIER, France, October 17, 2024--Regulatory News: Sensorion (FR0012596468 – ALSEN) a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent within the field of hearing loss disorders, today announces its participation in the 31st Congress of the European Society of Gene and Cell Therapy (ESGCT), held on October 22-25, 2024, in Rome, Italy. Business Wire ? 16 days ago ALSEN.PA -0.57% Performance Overview Trailing total returns as of 11/1/2024, which may include dividends or other distributions. Benchmark is CAC 40 Return ALSEN.PA CAC 40 YTD +62.79% -1.78% 1-Year +15.70% +7.60% 3-Year -63.35% +8.47%